Biocon Limited (BOM:532523)

Biocon Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue	173,211	169,270	152,617	147,557	111,742	81,840
Revenue Growth	9.83%	10.91%	3.43%	32.05%	36.54%	14.57%
Cost of Revenue	67,231	66,606	60,176	55,822	42,125	31,729
Gross Profit	105,980	102,664	92,441	91,735	69,617	50,111
Selling, General & Admin	40,074	39,244	34,948	28,514	23,321	20,531
Research & Development	-807	-1,137	-1,476	-838	-3,922	-4,764
Other Operating Expenses	29,114	27,769	26,638	30,526	23,434	14,611
Operating Expenses	89,150	85,721	77,010	73,901	53,974	38,528
Operating Income	16,830	16,943	15,431	17,834	15,643	11,583
Interest Expense	-9,013	-9,648	-8,877	-9,744	-4,190	-676
Interest & Investment Income	1,154	1,154	1,115	1,613	1,124	1,121
Earnings From Equity Investments	-	-	-	-842	-1,670	-2,069
Currency Exchange Gain (Loss)	-1,799	-1,799	-562	-523	-1,605	579
Other Non Operating Income (Expenses)	132	384	-86	4,288	39	7
EBT Excluding Unusual Items	7,304	7,034	7,021	12,626	9,341	10,545
Merger & Restructuring Charges	-1,372	-1,372	-	-	-470	-
Gain (Loss) on Sale of Investments	1,632	1,632	383	2,754	2,596	420
Gain (Loss) on Sale of Assets	-158	-158	10,497	-12	-52	-23
Asset Writedown	-	-	-86	-3,945	-	-
Other Unusual Items	-2,620	-2,657	1,051	3,829	-2,444	-1,111
Pretax Income	4,786	4,479	18,866	15,252	8,971	9,831
Income Tax Expense	622	791	4,572	2,274	2,541	2,115
Earnings From Continuing Operations	4,164	3,688	14,294	12,978	6,430	7,716
Net Income to Company	4,164	3,688	14,294	12,978	6,430	7,716
Minority Interest in Earnings	789	168	-4,161	-2,753	-1,803	-1,232
Net Income	4,953	3,856	10,133	10,225	4,627	6,484
Net Income to Common	4,953	3,856	10,133	10,225	4,627	6,484
Net Income Growth	28.65%	-61.95%	-0.90%	120.99%	-28.64%	-12.44%
Shares Outstanding (Basic)	1,470	1,366	1,197	1,195	1,193	1,191
Shares Outstanding (Diluted)	1,472	1,369	1,198	1,197	1,196	1,196
Shares Change	22.59%	14.22%	0.11%	0.08%	-0.04%	-0.03%
EPS (Basic)	3.37	2.82	8.46	8.55	3.88	5.44
EPS (Diluted)	3.37	2.82	8.46	8.54	3.87	5.42
EPS Growth	4.95%	-66.67%	-0.94%	120.67%	-28.60%	-12.44%

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	-	1,961	19,246	12,734	2,565	-5,212
Free Cash Flow Per Share	-	1.43	16.06	10.64	2.15	-4.36
Dividend Per Share	-	0.500	0.500	0.500	1.500	0.500
Dividend Growth	-	0%	0%	-66.67%	200.00%	-
Gross Margin	61.19%	60.65%	60.57%	62.17%	62.30%	61.23%
Operating Margin	9.72%	10.01%	10.11%	12.09%	14.00%	14.15%
Profit Margin	2.86%	2.28%	6.64%	6.93%	4.14%	7.92%
Free Cash Flow Margin	-	1.16%	12.61%	8.63%	2.30%	-6.37%
EBITDA	35,832	35,306	31,239	32,711	26,567	19,564
EBITDA Margin	20.69%	20.86%	20.47%	22.17%	23.77%	23.91%
D&A For EBITDA	19,002	18,363	15,808	14,877	10,924	7,981
EBIT	16,830	16,943	15,431	17,834	15,643	11,583
EBIT Margin	9.72%	10.01%	10.11%	12.09%	14.00%	14.15%
Effective Tax Rate	13.00%	17.66%	24.23%	14.91%	28.32%	21.51%
Revenue as Reported	176,384	172,695	164,699	156,212	115,501	83,967
Advertising Expenses	-	3,911	3,309	1,870	1,482	1,692

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error